Acquisition Opportunity Sight Sciences was acquired by Johnson & Johnson, presenting an opportunity for cross-selling ophthalmic devices and treatments alongside Johnson & Johnson's existing product portfolio.
Launching New Surgical Systems The recent launch of the Ergo-Series of the OMNI Surgical System in Europe indicates potential sales growth in the international market, offering a chance to expand the customer base and increase revenue streams.
Strong Financial Backing Securing a $65 million senior secured credit facility showcases financial stability, which can instill confidence in potential customers looking for long-term partnerships with financially sound vendors like Sight Sciences.
Competitive Positioning Identified as a competitor of Glaukos Corp., Sight Sciences can leverage its technology and clinical-proven therapies to differentiate itself, possibly attracting customers seeking innovative solutions.
Key Personnel Appointment The appointment of Matt Link as Chief Commercial Officer signifies a strategic move to drive sales growth. His expertise can lead to enhanced sales strategies and customer engagement, potentially creating new business opportunities.
Sight Sciences uses 8 technology products and services including SugarCRM, Font Awesome, Twitter Emoji (Twemoji), and more. Explore Sight Sciences's tech stack below.
| Sight Sciences Email Formats | Percentage |
| FLast@sightsciences.com | 93% |
| First@sightsciences.com | 4% |
| Last@sightsciences.com | 2% |
| FMiddleLast@sightsciences.com | 1% |
Medical Equipment ManufacturingCalifornia, United States201-500 Employees
We are reimagining eyecare with transformative technology and an interventional mindset. We believe interventions should happen sooner to preserve, protect, or restore natural eye function. So, we aim to provide eyecare providers with transformative, clinically-proven therapies that are intuitive, less invasive, and more intelligent.
Company Overview
Media & News
Funding & FinancialsSight Sciences has raised a total of $71M of funding over 3 rounds. Their latest funding round was raised on Mar 01, 2020 in the amount of $30Mas a Series E.
Sight Sciences's revenue is in the range of $10M$50M
Funding & FinancialsSight Sciences has raised a total of $71M of funding over 3 rounds. Their latest funding round was raised on Mar 01, 2020 in the amount of $30Mas a Series E.
Sight Sciences's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com